Company Filing History:
Years Active: 2016
Title: Tom Bretschneider: Innovator in Pharmaceutical Research
Introduction
Tom Bretschneider is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for medical applications. His work focuses on innovative solutions for treating serious diseases, including cancer.
Latest Patents
Bretschneider holds a patent for "Chartreusin analogues." This invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same, and their use for the treatment of cancer and other diseases. His innovative approach in this area showcases his commitment to advancing medical science.
Career Highlights
Tom Bretschneider is affiliated with the Leibniz Institute for Natural Product Research and Infection Biology. His role at this esteemed institution allows him to engage in cutting-edge research and collaborate with other experts in the field. His dedication to innovation is evident in his patent and ongoing research efforts.
Collaborations
Bretschneider has worked alongside notable colleagues, including Christian Hertweck and Hans-Martin Dahse. These collaborations have further enriched his research and contributed to the advancement of pharmaceutical sciences.
Conclusion
Tom Bretschneider is a distinguished inventor whose work in pharmaceutical research has the potential to impact the treatment of cancer and other diseases significantly. His innovative spirit and dedication to science continue to drive advancements in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.